# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
Discover the transformative effects of marijuana rescheduling on the cannabis industry, focusing on tax relief, financial impro...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already in...
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decisi...
Employees at Cresco Labs Inc.'s Fall River, Massachusets-based cannabis cultivation operations have voted overwhelmingly t...